CDEK
← All drugs Report issue

brii-196

mAbexperimental

Clinical trial activity

6 trials · 20 clinical orgs · 0 marketing orgs

Phase 1
2
Phase 2
4
Phase 3
2
Phase 4
0

Earliest trial started Jul 12, 2020 (NCT04479631)

Timeline

2020s

  1. Jan 1, 2020

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2020

    Earliest Phase 3 Sponsor(trial)

  3. Jan 1, 2021

    Earliest Phase 2 Sponsor(trial)

Indications

Studied for

Mechanism of action

  • SARS-CoV-2Immunity, passive

    SARS-CoV-2 immunity, passive

Chemistry & pharmacology

Multi-specific
No

Oral

No

Parenteral

No

Topical

No

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT04787211Phase 2Jun 20, 2021Brii Biosciences, Capital Medical University, Government of China, Guangzhou Medical University, Nanjing University, Shenzhen Third People's Hospital, Yunnan Provincial Infectious Disease Hospital
NCT04770467Phase 2Feb 28, 2021Brii Biosciences
NCT04691180Phase 1Dec 31, 2020Brii Biosciences, Government of China
NCT05780424Phase 3Dec 16, 2020AIDS Clinical Trials Group, Brii Biosciences, Cardiothoracic Surgical Trials Network, Department of Veteran Affairs, International Network for Strategic Initiatives in Global HIV Trials (INSIGHT), Medical Research Council, National Heart, Lung, and Blood Institute (NHLBI), National Institute of Allergy and Infectious Diseases (NIAID), University of Copenhagen, University of Minnesota, University of New South Wales
NCT04501978Phase 3Aug 4, 2020Brii Biosciences, Department of Veteran Affairs, Eli Lilly, GlaxoSmithKline, International Network for Strategic Initiatives in Global HIV Trials (INSIGHT), Medical Research Council, National Heart, Lung, and Blood Institute (NHLBI), National Institute of Allergy and Infectious Diseases (NIAID), University of Copenhagen, University of Minnesota, University of New South Wales, Vir Biotechnology, Inc.
NCT04479631Phase 1Jul 12, 2020Brii Biosciences, Government of China
Showing 6 of 6 trials
Page 1 / 1

Organizations

Research & Development (20)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Brii BiosciencesFor profit6432020
Government of ChinaGovernment3022020
Department of Veteran AffairsGovernment2012020
International Network for Strategic Initiatives in Global HIV Trials (INSIGHT)Academic/Hospital2012020
Medical Research CouncilGovernment2012020
National Heart, Lung, and Blood Institute (NHLBI)Government2012020
National Institute of Allergy and Infectious Diseases (NIAID)Government2212020
University of CopenhagenAcademic/Hospital2012020
University of MinnesotaAcademic/Hospital2012020
University of New South WalesAcademic/Hospital2012020
AIDS Clinical Trials GroupAcademic/Hospital1012020
Capital Medical UniversityAcademic/Hospital1012021
Cardiothoracic Surgical Trials NetworkAcademic/Hospital1012020
Eli LillyFor profit1012020
GlaxoSmithKlineFor profit1012020
Guangzhou Medical UniversityAcademic/Hospital1012021
Nanjing UniversityAcademic/Hospital1012021
Shenzhen Third People's HospitalAcademic/Hospital1012021
Vir Biotechnology, Inc.For profit1012020
Yunnan Provincial Infectious Disease HospitalAcademic/Hospital1012021
20 organizations
Page 1 / 1